https://synthekine.com/wp-content/uploads/logo-300x63.png00Emily Henneshttps://synthekine.com/wp-content/uploads/logo-300x63.pngEmily Hennes2022-04-07 08:00:422022-05-19 20:00:09Synthekine Announces Multiple Poster Presentations Showcasing Its Three Distinct Cytokine Engineering Platforms at American Association for Cancer Research (AACR) 2022 Annual Meeting
https://synthekine.com/wp-content/uploads/logo-300x63.png00Emily Henneshttps://synthekine.com/wp-content/uploads/logo-300x63.pngEmily Hennes2022-02-03 08:00:432022-05-19 20:00:40Synthekine Doses First Patient in Phase 1 Clinical Trial of IL-2 Partial Agonist, STK-012, for Treatment of Solid Tumors
